Please use this identifier to cite or link to this item: http://hdl.handle.net/2381/23462
Full metadata record
DC FieldValueLanguage
dc.contributor.authorBancroft, EK-
dc.contributor.authorLocke, I-
dc.contributor.authorArdern-Jones, A-
dc.contributor.authorD'Mello, L-
dc.contributor.authorMcReynolds, K-
dc.contributor.authorLennard, F-
dc.contributor.authorBarbachano, Y-
dc.contributor.authorBarwell, J-
dc.contributor.authorWalker, L-
dc.contributor.authorMitchell, G-
dc.contributor.authorDorkins, H-
dc.contributor.authorCummings, C-
dc.contributor.authorPaterson, J-
dc.contributor.authorKote-Jarai, Z-
dc.contributor.authorMitra, A-
dc.contributor.authorJhavar, S-
dc.contributor.authorThomas, S-
dc.contributor.authorHoulston, R-
dc.contributor.authorShanley, S-
dc.contributor.authorEeles, RA-
dc.date.accessioned2012-10-24T09:13:05Z-
dc.date.available2012-10-24T09:13:05Z-
dc.date.issued2010-07-
dc.identifier.citationJ MED GENET, 2010, 47 (7), pp. 486-491-
dc.identifier.urihttp://hdl.handle.net/2381/23462-
dc.description.abstractA novel oncogenetic clinic was established in 2002 at the Royal Marsden NHS Foundation Trust offering advice and specialist follow-up for families with a germline mutation in BRCA1 or BRCA2. The remit of this multidisciplinary clinic, staffed by individuals in both oncology and genetics, is to provide individualised screening recommendations, support in decision making, risk reducing strategies, cascade testing, and an extensive research portfolio.-
dc.formatmetadata-
dc.language.isoeng-
dc.sourcePubMed-
dc.source.urihttp://www.ncbi.nlm.nih.gov/pubmed/-
dc.subjectAdult-
dc.subjectAged-
dc.subjectApoptosis Regulatory Proteins-
dc.subjectBRCA1 Protein-
dc.subjectBRCA2 Protein-
dc.subjectBreast Neoplasms-
dc.subjectData Collection-
dc.subjectFemale-
dc.subjectHumans-
dc.subjectMale-
dc.subjectMiddle Aged-
dc.subjectMutation-
dc.subjectOvarian Neoplasms-
dc.subjectPreventive Medicine-
dc.subjectRetrospective Studies-
dc.subjectRisk Reduction Behavior-
dc.titleThe carrier clinic: an evaluation of a novel clinic dedicated to the follow-up of BRCA1 and BRCA2 carriers--implications for oncogenetics practice.-
dc.typeJournal Article-
dc.identifier.doi10.1136/jmg.2009.072728-
dc.identifier.eissn1468-6244-
dc.identifier.piijmg.2009.072728-
dc.description.irispid75665-
Appears in Collections:Published Articles, Dept. of Cancer Studies and Molecular Medicine

Files in This Item:
There are no files associated with this item.


Items in LRA are protected by copyright, with all rights reserved, unless otherwise indicated.